Novartis says positive interim results on rare kidney disease drug
Swiss pharmaceutical giant Novartis on Monday reported positive interim Phase III results for a new drug being studied to treat a rare kidney disease.
Oct 2, 2023
0
3
Swiss pharmaceutical giant Novartis on Monday reported positive interim Phase III results for a new drug being studied to treat a rare kidney disease.
Oct 2, 2023
0
3
Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests.
Oct 1, 2023
0
16
A new research paper titled "Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients" has been published inAging.
Sep 26, 2023
0
0
Dozens of diabetes patients in Pakistan suffered vision loss after being given a contaminated drug, a provincial health official said Tuesday.
Sep 26, 2023
0
1
Planning for the future is difficult for people living with a life-limiting illness. Clinicians, based on their experience, can offer broad estimates of survival—in days to weeks, weeks to months, or months to years. However, ...
Sep 25, 2023
0
2
Tumor vaccines can help the body fight cancer. These vaccines alert the patient's immune system to proteins that are carrying cancer-typical alterations.
Sep 21, 2023
0
15
Whether vaccinated or not, having at least four disease risk factors put adults hospitalized due to COVID-19 at higher risk for critical outcomes, according to a 10-state study from the Centers for Disease Control and Prevention's ...
Sep 19, 2023
0
3
Kids are back in school and it's time to think about viruses, for both yourself and them.
Sep 17, 2023
5
17
Half of patients discharged from the emergency department need only five tablets or fewer of morphine 5mg or an equivalent opioid pain killer, according to new research presented at the European Emergency Medicine Congress.
Sep 16, 2023
0
30
A new Oregon Health & Science University-led study reveals gaps in health insurance coverage for older Americans, who typically have more health issues than the rest of the population.
Sep 14, 2023
0
0